| | |
BDa
|
HF/HSb
|
Controlc
|
ANOVA
|
Post-hoc
|
|---|
|
Mean
|
SD_SE
|
Mean
|
SD_SE
|
Mean
|
SD_SE
|
p
| |
|---|
|
Body Composition
|
GLOBAL MASS (g)
|
495.5
|
33.3
|
729.7
|
67.0
|
627.1
|
62.8
|
0.000
|
a < c < b
|
|
GLOBAL FAT (g)
|
93.9
|
25.4
|
248.1
|
59.5
|
159.0
|
39.2
|
0.000
|
a < c < b
|
|
GLOBAL LEAN (g)
|
386.8
|
31.3
|
461.9
|
31.8
|
450.0
|
56.16
|
0.000
|
a < c.b
|
|
GLOBAL BMC (g)
|
14.75
|
0.99
|
19.71
|
1.61
|
17.96
|
1.90
|
0.000
|
a < c < b
|
|
Obesity Parameters
|
GLOBAL PFAT (%)
|
18.9
|
4.5
|
33.7
|
5.4
|
25.3
|
5.5
|
0.000
|
a < c < b
|
|
AC (cm)
|
21.2
|
0.7
|
26.5
|
1.4
|
23.4
|
1.3
|
0.000
|
a < c < b
|
|
CFM (g)
|
22.0
|
7.6
|
64.1
|
15.3
|
34.6
|
9.3
|
0.000
|
a < c < b
|
|
Perirenal AT (g)
|
10.6
|
3.4
|
34.5
|
7.5
|
12.6
|
3.4
|
0.000
|
a.c < b
|
|
Peri-epididymal AT (g)
|
9.2
|
2.7
|
25.5
|
5.6
|
16.3
|
3.5
|
0.000
|
a < c < b
|
|
ex vivo Fat Mass (g)
|
19.8
|
5.8
|
60.0
|
12.1
|
28.9
|
6.4
|
0.000
|
a < c < b
|
|
Lipid Profile
|
TRIGLY (g/l)
|
0.97
|
0.09
|
0.64
|
0.03
|
1.12
|
0.09
|
0.000
|
b < a.c
|
|
Total CHOL (g/l)
|
0.94
|
0.09
|
0.64
|
0.03
|
1.10
|
0.05
|
0.075
| |
|
HDL CHOL (g/l)
|
0.48
|
0.04
|
0.49
|
0.04
|
0.62
|
0.03
|
0.013
|
a.b < c
|
|
LDL CHOL (g/l)
|
0.27
|
0.07
|
0.28
|
0.03
|
0.26
|
0.03
|
0.258
| |
|
NEFA (mmol/l)
|
0.49
|
0.03
|
0.28
|
0.01
|
0.75
|
0.08
|
0.000
|
b < a < c
|
|
Hormonal Profile
|
INSULIN (ng/ml)
|
0.475
|
0.039
|
0.633
|
0.080
|
0.765
|
0.052
|
0.001
|
a < c
|
| |
LEPTIN (ng/ml)
|
4.300
|
0.448
|
19.144
|
0.915
|
10.692
|
1.246
|
0.000
|
a < c < b
|
| |
ADIPONECTIN (μgm/l)
|
11.292
|
0.590
|
12.563
|
0.762
|
12.240
|
0.689
|
0.443
| |
- Body composition and obesity parameters data are presented as mean ± SD. Lipid and hormonal profiles are presented as mean ± SE. AC = Abdominal Circumference. CFM = Central Fat Mass. AT = Adipose Tissues. CHOL = Cholesterol. NEFA = Non-Esterified Fatty Acids. BD n = 14. HF/HS n = 14. Control n = 15.
